| CRISPR Medicine | This is an overview of our most read articles
For the inaugural episode of CMN Live on 26th January 2024, we spoke with Eric Kmiec, Ph.D. about the successes of therapeutic gene editing to date,...
As 2023 draws to a close, we look back on some of the major clinical highlights from the year gone by.
Eligo Bioscience announced today the issuance by the US Patent and Trademark Office of a landmark CRISPR patent that broadly covers any therapeutic...
The last few months have seen many updates for gene-editing therapies in development for cancer, HIV, infectious disease and several inherited...
Gene editing has revolutionised research and is set to change the treatment landscape for genetic diseases, with >100 ongoing clinical trials across...
CRISPR Therapeutics and ViaCyte announced yesterday that Canada’s medical agency Health Canada has approved their clinical trial application for...
On Monday, Beam Therapeutics announced that the U.S. FDA had cleared BEAM-101 for clinical evaluation as a treatment for sickle cell disease. BEAM-101...
The FDA recently placed a temporary hold on a clinical trial with TALEN gene-edited CAR T-cells. A patient enrolled in this trial developed...
